SFA002

· SFA Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SFA002, covering 2025-01-09 to 2025-01-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques [Phase 1]